The Guardian has run a story today about this, quoting the Astra Zeneca boss, saying that
“The UK is probably one of the rare developed countries in the world that has not ordered Evusheld. It’s a sad situation, quite frankly, because people who are immune-compromised are really suffering from the Covid crisis"
Evusheld is a preventative antibody treatment, developed for immunosuppressed people, to try to stop them developing Covid, or developing so severely.
Hi Viv, It was much the same with Shingdrix, the non live shingles vaccine. Both the USA and Europe were using it long before the UK passed it for general usage for immunosuppressed patients. So I suspect that NICE will pass it for use in the UK before long.
Evusheld has already been approved for the immunosuppressed in the UK, by the Medicines and Healthcare products Regulatory Agency (MHRA) in March. I’m not sure if NICE need to do any more than that, but it’s possible the JCVI are still pondering slowly. But yes, it’s approved, so there shouldn’t be any good reason why it can’t be bought. Until it’s ordered from the makers rollout will be extra delayed.
I asked my consultant about this and she said that this and some others are not available to us yet. She said she favours the one trialled at Addenbrookes which is a nose spray you only have to use when you are going to be mixing with others. It would be good to know the reason it’s not available. I suspect it’s a cost thing.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.